CORE Biomedicine
CORE Biomedicine is a private, preclinical-stage biotechnology company that specializes in drug discovery and development for oncology.
CORE Biomedicine is a private, preclinical-stage biotechnology company that specializes in drug discovery and development for oncology.
CORE Biomedicine has raised $21.0M across 1 round. Its most recent round was a Series A of $21.0M in Jul 2026. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
CORE Biomedicine is featured in
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.